Biovie Inc (BIVI) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.27
• Market Cap: $11.23M
• EPS: $-12.12
• 52-Week High: $13.60
• 52-Week Low: $1.06

Market Sentiment

Biovie Inc currently has a Bullish sentiment score of 0.38.

About Biovie Inc

Biovie Inc. is a clinical-stage biotechnology company located in Santa Monica, California, dedicated to the discovery, development, and commercialization of innovative drug therapies targeting complex diseases with significant unmet medical needs. Utilizing its proprietary technologies, BioVie is strategically expanding its therapeutic portfolio to capitalize on emerging opportunities within the biopharmaceutical sector. Currently advancing through multiple clinical trials, the company is foc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biovie Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BIVI pay dividends?

Biovie Inc (BIVI) does not currently pay a regular dividend.

What is BIVI's market cap?

Biovie Inc (BIVI) has a market capitalization of $11.23M with a current stock price of $1.27.